Drug Shortage Report for LEDERLE LEUCOVORIN

Last updated on 2019-11-26 History
Report ID 98079
Drug Identification Number 02170493
Brand name LEDERLE LEUCOVORIN
Common or Proper name LEDERLE LEUCOVORIN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LEUCOVORIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 24
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-11-18
Estimated end date
Actual end date 2019-11-25
Shortage status Resolved
Updated date 2019-11-26
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-11-26 English Compare
v8 2019-11-25 French Compare
v7 2019-11-25 English Compare
v6 2019-11-19 English Compare
v5 2019-11-18 French Compare
v4 2019-11-18 English Compare
v3 2019-11-06 French Compare
v2 2019-11-06 English Compare
v1 2019-11-06 English Compare